{
  "directed": true,
  "graph": {
    "annotation_list": {},
    "annotation_pattern": {},
    "annotation_url": {
      "Anatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/anatomy/anatomy-20170511.belanno",
      "Cell": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell/cell-20170511.belanno",
      "CellLine": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-line/cell-line-20170511.belanno",
      "CellStructure": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/cell-structure/cell-structure-20170511.belanno",
      "Confidence": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/confidence/confidence-1.0.0.belanno",
      "Disease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/disease/disease-20170511.belanno",
      "MeSHAnatomy": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-anatomy/mesh-anatomy-20170511.belanno",
      "MeSHDisease": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/mesh-diseases/mesh-diseases-20170511.belanno",
      "Subgraph": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/neurommsig/neurommsig-1.0.3.belanno",
      "TextLocation": "https://arty.scai.fraunhofer.de/artifactory/bel/annotation/text-location/text-location-1.0.1.belanno"
    },
    "document_metadata": {
      "authors": "Sandra Spalek",
      "contact": "charles.hoyt@scai.fraunhofer.de",
      "copyright": "Copyright © 2018 Fraunhofer Institute SCAI, All rights reserved.",
      "description": "",
      "licenses": "CC BY 4.0",
      "name": "Inflammasome activation and innate immunity in Alzheimer’s disease",
      "version": "1.0.2"
    },
    "namespace_pattern": {
      "DBSNP": "rs[0-9]+",
      "TAXONOMY": "^\\d+$"
    },
    "namespace_url": {
      "CHEBI": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/chebi-names.belns",
      "CONSO": "https://raw.githubusercontent.com/pharmacome/conso/501ceccdc9a27d97edbdc48a89ebe8e1dd3626e9/export/conso.belns",
      "DRUGBANK": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/drugbank-names.belns",
      "ECCODE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/ec-code.belns",
      "FPLX": "https://raw.githubusercontent.com/sorgerlab/famplex/e8ae9926ff95266032cb74f77973c84939bffbeb/export/famplex.belns",
      "GO": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/go-names.belns",
      "HGNC": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/hgnc-names.belns",
      "HP": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/hp/hp-20171108.belns",
      "INTERPRO": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/interpro/interpro-20170731.belns",
      "MESH": "https://raw.githubusercontent.com/pharmacome/terminology/1b20f0637c395f8aa89c2e2e342d7b704062c242/external/mesh-names.belns",
      "MGI": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/mgi-mouse-genes/mgi-mouse-genes-20170725.belns",
      "NCBIGENE": "https://raw.githubusercontent.com/pharmacome/terminology/b46b65c3da259b6e86026514dfececab7c22a11b/external/entrez.belns",
      "RGD": "https://arty.scai.fraunhofer.de/artifactory/bel/namespace/rgd-rat-genes/rgd-rat-genes-20170725.belns"
    },
    "namespaces_uncached": [],
    "path": "inflammasome/heneka2017.bel",
    "pybel_version": "0.13.2"
  },
  "links": [
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Innate immune system subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "One of the canonical pathways of this innate immune response evoked by Abeta is the activation of the NOD-like receptor (NLR) family, pyrin domain containing 3 (NLRP3) inflammasome that became a focus of intense research",
      "key": "041a3262e3667d35f34f0b37b0c4cb170730ca30636eeaf897fd6ee24b5e7899efd1abdd13fdfb87e4062693ee1fe0d22e0fdcbfc439678a5aea628cdd9245bd",
      "line": 74,
      "relation": "increases",
      "source": 2,
      "target": 7
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome activation results from TLR ligation and concomitant uptake of Ab in models of AD",
      "key": "e8d73aebadee331a0d8748b99fca5b2829aa26ba2b34f3f1b3c3c5ef15788ee7b8b9c15fb36104ad1ee0163f3a099fe24be108e9e0dd179ad339bc22ed49e69f",
      "line": 83,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Nitric oxide subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "d7584314bac6a5ecf12512954b1369cd0dd969e4287a1045722320f2148933bc134691a30a58fc3437c71ef430368c4c5d765f1228aa259d3f1ac19c1d525874",
      "line": 126,
      "relation": "increases",
      "source": 2,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Tumor necrosis factor subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "fa434d19d842c630c48f4803291362048dc8f7e4dc01e42a4c99f1265e45fdfef96e8c544f5a06946eb242ea360a7a6df8f86780bd8d0ae95d660b0f03c51b4b",
      "line": 133,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 2,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Further data, showing “neuronal pyroptosis” of Abeta exposed neurons in a NLRP1- dependent and caspase-1-mediated manner may point to a vicious cycle, by which NLRP1 is causing neurodegeneration in response to increased Abeta production (14)",
      "key": "7c9b8fcb134993e4aa31e243d6953a2a453a9b08ef2cc2885aa63681dc5e90034fd2d3ebce995fb6453300841b25842aa8b4c5a4cc27bd8b21e0b4e7fe89bc41",
      "line": 169,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 9
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Apoptosis signaling subgraph": true,
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Further data, showing “neuronal pyroptosis” of Abeta exposed neurons in a NLRP1- dependent and caspase-1-mediated manner may point to a vicious cycle, by which NLRP1 is causing neurodegeneration in response to increased Abeta production (14)",
      "key": "653eda9d67fe048fa4effbadbf0adc85b3325e1cda7c1bdfe9981be28d98c1fee9c6165b6687d036f199d1c9f317946708cf96cbaf9305660626ec8718e46b82",
      "line": 177,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 2,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Innate immune system subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "One of the canonical pathways of this innate immune response evoked by Abeta is the activation of the NOD-like receptor (NLR) family, pyrin domain containing 3 (NLRP3) inflammasome that became a focus of intense research",
      "key": "dfe4761881a87fda2266e87974fb391a70846a9ebb824ffebaaf8e31c12bb221e91c827bb63931f2510e9992e0afa6696dd792ff76d9590acc4969dd0df60f46",
      "line": 75,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 7,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Activation of NLRP3 leads to the generation of interleukin-1b (IL-1b) and interleukin 18 (IL-18), which are being cleaved by caspase-1 from their inactive precursors and subsequently",
      "key": "0311d9e8b2a28a225d0e9cd30539bd18a0029fbbcbbdffca468f39620ca560c4a035d9c43d2d445daf804857656e8eb69dae63c34ae90bdc7106ff0b892db43c",
      "line": 95,
      "relation": "increases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Activation of NLRP3 leads to the generation of interleukin-1b (IL-1b) and interleukin 18 (IL-18), which are being cleaved by caspase-1 from their inactive precursors and subsequently",
      "key": "bc53fe6d2159c2f9e6d682abe30effd552a60a8818c5f7b8b49f768e5750d884b8f4f685f025c93462458ba6210960948a0a0a4fc6c99b2f12bcca8d95cfadbc",
      "line": 96,
      "relation": "increases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using the herbizide, N,N0-dimethyl-4,40-bipyridinium dichloride (paraquat) as a mitochondrial toxin, which is known to induce oxidative stress, Chen et al. found increased levels of caspase-1 and IL-1b in brain of wild type and APP/PS1 transgenic mice (2), suggesting that those were due to NLRP3 inflammasome activation",
      "key": "04f9549850443b493b9014edf6e3832dc532ebf33e757873233376ad07e91dc2bd7d2695cda80cbaf458fb27b9fdf7f2c1bab0db9c7fef432dd0f0a6ea6cfbc8",
      "line": 214,
      "relation": "increases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "b535ac3554bf5257f6cd6e3888aa0b5b44163fdd7693369144c41871f1254e92465081e080bf3b9f8a164cc431820ff2ef563c77b1168ea179ea46411f53d376",
      "line": 123,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 10,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using the herbizide, N,N0-dimethyl-4,40-bipyridinium dichloride (paraquat) as a mitochondrial toxin, which is known to induce oxidative stress, Chen et al. found increased levels of caspase-1 and IL-1b in brain of wild type and APP/PS1 transgenic mice (2), suggesting that those were due to NLRP3 inflammasome activation",
      "key": "f5bdf38f1719acfded9e7973860217f03bfa7112c28ef5417199a3399d1807def1ed3b322a9a49c39d7d4c484d49e825f55ab6a265ef0ca4cfe7c0bb64ef0a92",
      "line": 210,
      "relation": "increases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Nitric oxide subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "9499218f206a73df389338ff8f2959eaf8d0b16c161e74da8c5baed41b622616724d5219dbd087d3e5cc9e54aea4efc613a0fd4352ed6a271f8ea218ea9d5d4d",
      "line": 129,
      "relation": "increases",
      "source": 10,
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Tumor necrosis factor subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "f9ace2c4b5137d235e4b6c279b6cbea6eb2940dfcd9c669eaafdf8be3168721c826d64ca6538efcb1d31eb791896fdedb3cdb468587053e47b9ca9e3efc0df78",
      "line": 134,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 10,
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "This finding was associated with spatial memory dysfunction and an increase in Abeta plaque deposition",
      "key": "b70a5c38ac6c872f275c10c85e0e2a0f97dc55de152dc7f733b9188f31adf08c9975981324c4739b374e03f76f41986da66ae642d7427cea9c27cdb977a3d396",
      "line": 222,
      "relation": "decreases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 23
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "This finding was associated with spatial memory dysfunction and an increase in Abeta plaque deposition",
      "key": "c8fbbe482391f1ff4af7cca9dc977ee883cb92cddf6e8b7a1a6a2ee5113521c917a3906ddc8cd98c07ecb1871859ccfe749100572c3e85a0d255d31174d3ba93",
      "line": 223,
      "relation": "increases",
      "source": 10,
      "subject": {
        "modifier": "Activity"
      },
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Toll like receptor subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome activation results from TLR ligation and concomitant uptake of Ab in models of AD",
      "key": "cf0edbfa6f3c2fcd6f6f6583215773a88749dda5d47ccd2b29eff40dd5def010387b1370f6bf3f79d22cc4c4c83119ee22e73213aa64c545f09d3901b06b57e7",
      "line": 86,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 6,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Activation of NLRP3 leads to the generation of interleukin-1b (IL-1b) and interleukin 18 (IL-18), which are being cleaved by caspase-1 from their inactive precursors and subsequently",
      "key": "7a0f8c62f00f0b8112e1b05f70c624df6c23a2274789d8a84527a7d2d5356efa7e1bb62b56c9dcedfa1aab2b64609e293339d1c661c4ad76327a78e905f8ecd2",
      "line": 97,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 13,
      "target": 18
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Activation of NLRP3 leads to the generation of interleukin-1b (IL-1b) and interleukin 18 (IL-18), which are being cleaved by caspase-1 from their inactive precursors and subsequently",
      "key": "df6f76ab2cb8730f9dcbf57593aa0b20c4899758bb0e4cb4524d54f82f15cc8a431f8a33447e3dcd90ef9d7d6b84a65c570995fa91bedc0a931da2e1401bb35f",
      "line": 98,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 13,
      "target": 19
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Nitric oxide subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "af6196a33a9fdbf651dc370b5fb00921fc3e31f5ab85c92b47a9500e1a91677fdb1cf3801fdd0909a1fea15cd1347bc32a77181871cb0c09f77b68815536a925",
      "line": 130,
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 3
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true,
          "Tumor necrosis factor subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 inflammasome formation and subsequent activation of caspase-1 cleavage capacity was instrumental for Abeta-induced nitric oxide production and TNF-a release",
      "key": "8d8fa50b344023e3f484e6712d2a1b2ba9beaace74a2932379dbc80e6173dbdf4141d29e2dc6392e228d0768ecad46fed0a74ce329cf47c987539c9966369f18",
      "line": 137,
      "object": {
        "effect": {
          "fromLoc": {
            "name": "intracellular",
            "namespace": "bel"
          },
          "toLoc": {
            "name": "extracellular space",
            "namespace": "bel"
          }
        },
        "modifier": "Translocation"
      },
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 20
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Apoptosis signaling subgraph": true,
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Further data, showing “neuronal pyroptosis” of Abeta exposed neurons in a NLRP1- dependent and caspase-1-mediated manner may point to a vicious cycle, by which NLRP1 is causing neurodegeneration in response to increased Abeta production (14)",
      "key": "71ebf0550ab220968872c6d9da4a54c4c30e0f58a6b8efa4109937b739d63b11349bdad4a1d2ff59e40905c66d8168b7c2a56abdd0863edf1f1bbe93c9551162",
      "line": 178,
      "relation": "increases",
      "source": 13,
      "subject": {
        "modifier": "Activity"
      },
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Activation of the NLRP3 inflammasome by fibrillar Abeta has been described first by Halle et al. in 2008",
      "key": "96e73195a2fe89d1291f4dc835f541da930fc73c4d8411ff644e37e22b094f6f098c6224517d0ac4e577e1691480b1e946b0fe6165c508dc9a9e5d400cc24b13",
      "line": 106,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 5,
      "target": 10
    },
    {
      "key": "3424708417880f1ae82dc19e949ca92921845babb3976cc889ac349d2a5f368a38ccdf1d87a226f6b3290ef45c166175f1bbd176ee7733653a70e574e894a95b",
      "relation": "hasComponent",
      "source": 12,
      "target": 2
    },
    {
      "key": "043c4b3f44afa081837b1000dcb24dcea939d6082dfc5c79656583813da12e2dcc14da4bf4730257129a6f38a658f9f071d7d4e338b9a0abb3db0ca24722479c",
      "relation": "hasComponent",
      "source": 12,
      "target": 16
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "NLRP3 activation was characterized by ASC speck formation in an immune-activated microglial cell line and required a dual signal to become effective: the phagocytic uptake of Abeta and cathepsin B release after lysosomal disruption",
      "key": "571a5c692dd9d6964233731d415bd79a7aecab129b744ceb2118d24ad5c25d15f76f4cff767cadc87f474bcf8015f2a81a105ed9320cd0d8e18fb0e2cada03c3",
      "line": 115,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 12,
      "target": 10
    },
    {
      "key": "1e553c9dd9f869e0e221994cdcdca6d2bb1a6b1c7835a1551def207e5ee99be5c51ef0ef545ae524ab7ee9bd94cb95ed256bcec828866c31a5ec6cbfa3066843",
      "relation": "hasComponent",
      "source": 11,
      "target": 2
    },
    {
      "key": "331410e4dbf651c7eca2a3772b92bb66620b046bc7ac6d145f5071a11021c86a8d2cfa7ec1f9e5b486ded5e004c022464b920f0ec3969a5d60cfb36b895a5ce5",
      "relation": "hasComponent",
      "source": 11,
      "target": 15
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Soluble Abeta (sAbeta)-induces NLRP3 inflammasome activation, however it requires the presence of the surface receptor CD36 (12)",
      "key": "8d167929481a21337442daf2d0167a12a23864d9c009353660e4726f0a22aae4f6a723f011e1d4ef40facc5a80fcddc5a37e79b00699b830290bab514724d077",
      "line": 145,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 11,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Recently, Kaushal et al. described the involvement of NLRP1 inflammasome activation in neurons. In these experiments, serum deprivation induced NLRP1-dependent caspase-1 activity and ASC speck formation, which resulted in caspase-6 activation and an increase in the Ab42/total Ab ratio (11)",
      "key": "03dc4ae359035f3175cb03e4d77d19245e50cb8e4efd3dfc56f4a8e2fc02fcf7dc9e2aad69edb87f0d3fa77067e967ac2b2f1d671a010e6e7737241588cadf34",
      "line": 155,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Recently, Kaushal et al. described the involvement of NLRP1 inflammasome activation in neurons. In these experiments, serum deprivation induced NLRP1-dependent caspase-1 activity and ASC speck formation, which resulted in caspase-6 activation and an increase in the Ab42/total Ab ratio (11)",
      "key": "c362fd7c252d89f50f1f0b7c18d141d1bf7f886c1c50a8b8b0902aed3e64a9f8a9d85a617990108c351486c5fe80ae018331f1e47d9705b3b2e82eaf05c9fd95",
      "line": 156,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 9,
      "subject": {
        "modifier": "Activity"
      },
      "target": 14
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Recently, Kaushal et al. described the involvement of NLRP1 inflammasome activation in neurons. In these experiments, serum deprivation induced NLRP1-dependent caspase-1 activity and ASC speck formation, which resulted in caspase-6 activation and an increase in the Ab42/total Ab ratio (11)",
      "key": "b5cbf79840d5662b7dbfb9e03db30f0de9994c83571932e5746e6d3aa74ba31125294c2571295d0eef65b8154481b0d08b4a18475565e953ee377248477941d9",
      "line": 159,
      "relation": "increases",
      "source": 9,
      "subject": {
        "modifier": "Activity"
      },
      "target": 1
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Apoptosis signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Further data, showing “neuronal pyroptosis” of Abeta exposed neurons in a NLRP1- dependent and caspase-1-mediated manner may point to a vicious cycle, by which NLRP1 is causing neurodegeneration in response to increased Abeta production (14)",
      "key": "7240d478528a8f6cb7b9c9f7d261b8673b438d6889fe68ee57f817b5c580c9f1594c59b72cefc86a9ccf7aba0fc27763521434c43e042b1b89a4e68b79d4bbfc",
      "line": 172,
      "relation": "increases",
      "source": 9,
      "target": 8
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Apoptosis signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Further data, showing “neuronal pyroptosis” of Abeta exposed neurons in a NLRP1- dependent and caspase-1-mediated manner may point to a vicious cycle, by which NLRP1 is causing neurodegeneration in response to increased Abeta production (14)",
      "key": "2e315b19ab3db013717f37078a37b08c290c359e9a2d45f4651548d963d0e5225a5cbfdd8192064375b8a5b15d5bd54eb644ae735c7bd6cc5b87aecef5ca2274",
      "line": 173,
      "relation": "increases",
      "source": 9,
      "target": 22
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Insulin signal transduction": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "The combined effect of the increased IDE production and phagocytic Abeta clearance reduced the cerebral Abeta load substantially, even at late life. Since immunohistochemistry found NLRP3 exclusively expressed in microglial cells, it has been concluded that the observed changes were entirely due to NLRP3 inflammasome modulation in these cells",
      "key": "af7d1b3708163981609e66963eea70dbcd43e42afe71d20d9c8b48a3fa5fc591440b7f01da131bd79b1770a1e78bc7f3167f73f9a22645305d38d666593242ff",
      "line": 188,
      "relation": "decreases",
      "source": 17,
      "target": 2
    },
    {
      "annotations": {
        "Confidence": {
          "Medium": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Amyloidogenic subgraph": true,
          "Insulin signal transduction": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "The combined effect of the increased IDE production and phagocytic Abeta clearance reduced the cerebral Abeta load substantially, even at late life. Since immunohistochemistry found NLRP3 exclusively expressed in microglial cells, it has been concluded that the observed changes were entirely due to NLRP3 inflammasome modulation in these cells",
      "key": "718404684175a5d4296af3f4782601731ec7aa3e38d8d3777d0072bb88083ac83c88662bcecf001fa8af48de179bb80fb9fec7a24a0bfe3bd527668df6f85600",
      "line": 189,
      "relation": "regulates",
      "source": 17,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Nuclear factor Kappa beta subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using a similar mouse model, Shi et al. treated animals with the antimalarial drug artemisinin, showing that this treatment results in inhibition of NFkB and presumably the NLRP3 inflammasome (13)",
      "key": "784a3e07349e16623673a5a451bd57dce5dd00f0cc27c2660e728792ea7ed006b3c4dc03ed27eafe71ac097e3e8dd9bff32f268f104b5f4f95731caf4f8e11d2",
      "line": 197,
      "relation": "decreases",
      "source": 0,
      "target": 21
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Nuclear factor Kappa beta subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using a similar mouse model, Shi et al. treated animals with the antimalarial drug artemisinin, showing that this treatment results in inhibition of NFkB and presumably the NLRP3 inflammasome (13)",
      "key": "3468aa67bc953dcccc6a3bd03637ba6b2c555febb9fd4fb11ab129ec90791a5043c6125d9805584c3c2586f0249f531456970247695601684730454e91e5d390",
      "line": 198,
      "relation": "decreases",
      "source": 0,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using the herbizide, N,N0-dimethyl-4,40-bipyridinium dichloride (paraquat) as a mitochondrial toxin, which is known to induce oxidative stress, Chen et al. found increased levels of caspase-1 and IL-1b in brain of wild type and APP/PS1 transgenic mice (2), suggesting that those were due to NLRP3 inflammasome activation",
      "key": "cad8d4d2c6863ccdc6749c54189b96bba1364ba6323115e7d7d5d75e17348a9fe0a6802e05c3825e09fcab3e7235989e60788792c79223aba0946195c47688d7",
      "line": 208,
      "object": {
        "modifier": "Activity"
      },
      "relation": "increases",
      "source": 4,
      "target": 10
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Caspase subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using the herbizide, N,N0-dimethyl-4,40-bipyridinium dichloride (paraquat) as a mitochondrial toxin, which is known to induce oxidative stress, Chen et al. found increased levels of caspase-1 and IL-1b in brain of wild type and APP/PS1 transgenic mice (2), suggesting that those were due to NLRP3 inflammasome activation",
      "key": "cb8180805e6746b2383a7f844e695499b5e6dd36d5e521ee4ffed26a98d9efb33448a2a205fc6c402e7426a2766f0169756b540904173a5e4a18ac5203ce1fdf",
      "line": 209,
      "relation": "increases",
      "source": 4,
      "target": 13
    },
    {
      "annotations": {
        "Confidence": {
          "High": true
        },
        "MeSHAnatomy": {
          "Neurons": true
        },
        "Subgraph": {
          "Interleukin signaling subgraph": true
        }
      },
      "citation": {
        "authors": [
          "Heneka MT"
        ],
        "date": "2017-03-01",
        "first": "Heneka MT",
        "last": "Heneka MT",
        "name": "Brain pathology (Zurich, Switzerland)",
        "pages": "220-222",
        "reference": "28019679",
        "title": "Inflammasome activation and innate immunity in Alzheimer's disease.",
        "type": "PubMed",
        "volume": "27"
      },
      "evidence": "Using the herbizide, N,N0-dimethyl-4,40-bipyridinium dichloride (paraquat) as a mitochondrial toxin, which is known to induce oxidative stress, Chen et al. found increased levels of caspase-1 and IL-1b in brain of wild type and APP/PS1 transgenic mice (2), suggesting that those were due to NLRP3 inflammasome activation",
      "key": "e159fdb75554e49454dc953310336e3118ac2214095f5c8857ac0676525895ae847f9ccc35bfec5b23d3f69cc9d0a92b5c5309c1b2e874e2c01cac119cb9ef3c",
      "line": 213,
      "relation": "increases",
      "source": 4,
      "target": 19
    }
  ],
  "multigraph": true,
  "nodes": [
    {
      "bel": "a(CHEBI:\"(+)-artemisinin\")",
      "function": "Abundance",
      "id": "949f6ba04a6f1e1aff1fe19cec84e554efee6faf246ece27a501160a5450f6e54fef0fb6f51756661e01a705f42e22dd7fc15157e4d8041f3e5703b3f560af0a",
      "name": "(+)-artemisinin",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta polypeptide 42\")",
      "function": "Abundance",
      "id": "c2da54109c90719396dfdfb558be74582b8522863849a50f3f5029b7d60f4d53df3cfa1a97b787e760a2f74ea1f74012eb49273beeded42a2873d788953b4a13",
      "name": "amyloid-beta polypeptide 42",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"amyloid-beta\")",
      "function": "Abundance",
      "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
      "name": "amyloid-beta",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:\"nitric oxide\")",
      "function": "Abundance",
      "id": "fd0dcffbd4e00c161d74c931890123439e35f86a92cbcf20c1efaed0bb8b8469434bbafd8364de8822b9af6368de418ed1728b1534bb8eeb47320d5a9c895548",
      "name": "nitric oxide",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CHEBI:paraquat)",
      "function": "Abundance",
      "id": "fd3ecd675e476ded20dfe73d049515216e33dc46d27e36ec26d483d592750cece35ddf987b660d04495459c69aad887af8d11c1c4b45b53159dfdd3e012868fb",
      "name": "paraquat",
      "namespace": "CHEBI"
    },
    {
      "bel": "a(CONSO:CONSO00038)",
      "function": "Abundance",
      "id": "48408e8766312f2d9b3ed800c1146918164032d6f743f3114e12e3b60e3cee257e7d5c07382a4f52aa4f27ddfcdc85fd9dfbad8daee3fa065d39fa0eda76f96d",
      "name": "CONSO00038",
      "namespace": "CONSO"
    },
    {
      "bel": "a(MESH:\"Toll-Like Receptors\")",
      "function": "Abundance",
      "id": "faced6e58ec8872d734ecf79b0465956c8f7ba84f6f4be2ca88cdcbdfd83e1b990991a819b5280c35dd5549c87dcabc398834485f0653da85d7fecdb9c6271b8",
      "name": "Toll-Like Receptors",
      "namespace": "MESH"
    },
    {
      "bel": "bp(GO:\"innate immune response\")",
      "function": "BiologicalProcess",
      "id": "5c8d09abf581d5f0a2311faab9baf15a3f6b755cb951f5758225c589ab68037dbd4f15f6f7f52c63f249225aaa58b38b402f43b19c77f320d5a2821c55aa2e85",
      "name": "innate immune response",
      "namespace": "GO"
    },
    {
      "bel": "bp(GO:pyroptosis)",
      "function": "BiologicalProcess",
      "id": "cc4f783cf3a6b4502dfe393447687aac4afa8d4716985c89eb68f021dbed43f26482337d7a606b300143ab24a9dd1bfefd61146657f2ed7bfaa8de931df98b98",
      "name": "pyroptosis",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"NLRP1 inflammasome complex\")",
      "function": "Complex",
      "id": "1c118e83968a4ececac5c9a54f46ce775bfe73e0ba9b6e9f3fc7f2e843d0fa2f3fd35b83447b6040faa3da489af5dd7f239fe4138751f1587a71a8bea59c1c50",
      "name": "NLRP1 inflammasome complex",
      "namespace": "GO"
    },
    {
      "bel": "complex(GO:\"NLRP3 inflammasome complex\")",
      "function": "Complex",
      "id": "425efd88f8461922a6bca9566d793b49ce565888efd2d2bbfc1cf009516e8e83dbc867d11ad88cef05d1aa6e0b506e74827fc714434377ff0a4e3dd94d2d172c",
      "name": "NLRP3 inflammasome complex",
      "namespace": "GO"
    },
    {
      "bel": "composite(a(CHEBI:\"amyloid-beta\"), p(HGNC:CD36))",
      "function": "Composite",
      "id": "cbe358b423eec60e10d05ccf219a6695c99c519dc0ac3f31fb365c52f892a03b5880536a4b965117e2321e96b34d40244b0dc0010068bfe96e68deda0860984b",
      "members": [
        {
          "bel": "a(CHEBI:\"amyloid-beta\")",
          "function": "Abundance",
          "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
          "name": "amyloid-beta",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:CD36)",
          "function": "Protein",
          "id": "4512f12495547840f0260acfe233ba109f43e460b35b011d2f8a91b9ead5272da9e00b0d92c3bb6bb8ed0c6313e83f876d7cb12e6f212bd2124d5800cfcaff20",
          "name": "CD36",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "composite(a(CHEBI:\"amyloid-beta\"), p(HGNC:CTSB))",
      "function": "Composite",
      "id": "061b02cbeb544c726a0a135248c84ac410df5b4254eccb32eeecf41b9931defd47ea9e3c0e421327847d260af867241aa0332549028d27d0cb4e71215d135b2d",
      "members": [
        {
          "bel": "a(CHEBI:\"amyloid-beta\")",
          "function": "Abundance",
          "id": "a9487b29439483c6840095610dd3e496e3ca9cccc3a8d71e0385a39b570f3c0a26965ac06d83265e1c08deaae7998272d4f4c21ec0534f8be3fd8e4e57dbb3a2",
          "name": "amyloid-beta",
          "namespace": "CHEBI"
        },
        {
          "bel": "p(HGNC:CTSB)",
          "function": "Protein",
          "id": "770e5c1dacf84a7f13d61edc8b73235143273ea3811f8076af71ae88a96ca93d99874731416edb99f2d91b8d8a06d86f8ca6ab848261f03a60af0657f4838168",
          "name": "CTSB",
          "namespace": "HGNC"
        }
      ]
    },
    {
      "bel": "p(HGNC:CASP1)",
      "function": "Protein",
      "id": "573c1f59f79260b0e8231f27d98abeece26f3766396d321ebfa7b7b383c97b58b352e2a1d09292a03153a23832e0349cde21b58fd43b5609c74bbfdabf271d9c",
      "name": "CASP1",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CASP6)",
      "function": "Protein",
      "id": "aa1ccaf1ee68bf17a453b904f4cb24a53e38db74e660997982be7a73c134ff6bc11e1dca9345dab9e5589e070525f784b03e7dbcfaeece8da7a2ae2de3c4df58",
      "name": "CASP6",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CD36)",
      "function": "Protein",
      "id": "4512f12495547840f0260acfe233ba109f43e460b35b011d2f8a91b9ead5272da9e00b0d92c3bb6bb8ed0c6313e83f876d7cb12e6f212bd2124d5800cfcaff20",
      "name": "CD36",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:CTSB)",
      "function": "Protein",
      "id": "770e5c1dacf84a7f13d61edc8b73235143273ea3811f8076af71ae88a96ca93d99874731416edb99f2d91b8d8a06d86f8ca6ab848261f03a60af0657f4838168",
      "name": "CTSB",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IDE)",
      "function": "Protein",
      "id": "ef40c2282a9443979f4a3a31bbd42f8d713281448c6551e853da09d253ebc0bfe8c17ea3042707bdf539f2c0921898b22e8ce3af7a86ec859c803801af7d8ce5",
      "name": "IDE",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL18)",
      "function": "Protein",
      "id": "c2ae47fb807189ff073d8164094e73f252cec8d4affa55f62b978a89cd314f3f0f193673bbe040c66b7d0078c553b9a787df987130a99442bb387f64ba21f0b6",
      "name": "IL18",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:IL1B)",
      "function": "Protein",
      "id": "bd7736973dc00dadc09dff75214ff05344d2e9b6dfbc09a364f08b7cae84142149292551bd60d5addd6130e971c2ccd4c73b963ad918ad9b0a418b94e5a30cfd",
      "name": "IL1B",
      "namespace": "HGNC"
    },
    {
      "bel": "p(HGNC:TNF)",
      "function": "Protein",
      "id": "a262f5edbfb734dd0ec9696a3b78644fccfb4054a9cf9225beb17c33ef416a75809ff59ec1646e29a3cccc804c9294f8d2c48120af9f5ee98e764a584626426d",
      "name": "TNF",
      "namespace": "HGNC"
    },
    {
      "bel": "p(MGI:Nfkbia)",
      "function": "Protein",
      "id": "45f1f014af2abb845177dbd5690f5831b98cfbe1154aa6db7226afa618909d1e0fad14d7d02f32a27cc432ad6ed26d82428646de3444b6eab7760c2d8135784c",
      "name": "Nfkbia",
      "namespace": "MGI"
    },
    {
      "bel": "path(CONSO:CONSO00027)",
      "function": "Pathology",
      "id": "08d0324fd04b927a9f606c1c400015efe39c626fcd7c8aac5cd7ae311f38c48caeba1e381d651435f2b956f28561e2fc0d1ab21f0517346e4978215c9eecda00",
      "name": "CONSO00027",
      "namespace": "CONSO"
    },
    {
      "bel": "path(MESH:\"Spatial Memory\")",
      "function": "Pathology",
      "id": "7617bc77b1deb949824e3cb1b4d2c858cd784ace0d2c41934e19bdeb43b399553629ec153ef25e9e2c80d2389dfc60de193a290e2fb966544d5769aba98f1358",
      "name": "Spatial Memory",
      "namespace": "MESH"
    }
  ]
}